Skip Navigation

COVID-19: We are vaccinating patients ages 12+. Learn more:

Vaccines, Boosters & 3rd Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker | Email Alerts

 

Philips Respironics issued a recall for some CPAP and BiLevel PAP devices and mechanical ventilators. Learn more.

Challice Bonifant, M.D., Ph.D.

Headshot of Challice Bonifant
  • Assistant Professor of Oncology

Specializes in: Adolescents (12-18 years), Children (1-11 years), Infants (up to 1 year)

Expertise

Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML) ...read more

Research Interests

Immunotherapy of cancer; malignant hematology; engineered cellular immunotherapies for the treatment of Acute Myeloid Leukemia ...read more

Request an Appointment

Insurance Information

Main Phone

410-955-8751

Outside of Maryland

410-464-6641
Request Appointment

International Patients

+1-410-502-7683
Request Appointment

Locations

The Johns Hopkins Hospital (Main Entrance)

Appointment Phone: 410-955-8751
1800 Orleans St.
The Charlotte R. Bloomberg Children's Center Building, 11th Floor
Baltimore, MD 21287 map

Background

Dr. Bonifant is a pediatric oncologist on the blood and marrow transplantation team at the Sidney Kimmel Comprehensive Cancer Center and an Assistant Professor of Pediatric Oncology at the Johns Hopkins University School of Medicine. She is also a member of the Bloomberg-Kimmel Institute for Immunotherapy. Her clinical specialty is stem cell transplantation for high-risk leukemias.

Her research interests are in the areas of immunotherapy of cancer and malignant hematology. Currently, her research focuses on design and development of immune therapies as a treatment for poor-prognosis cancers, including development of engineered cellular immunotherapies for the treatment of Acute Myeloid Leukemia.

Dr. Bonifant is a graduate of Wake Forest University and Georgetown University. She completed her Pediatric and Hematology/Oncology training at Johns Hopkins and at Baylor College of Medicine. Prior to her appointment at Johns Hopkins, she was an Assistant Professor in Pediatrics-Hematology/Oncology at the University of Michigan.

...read more

Titles

  • Assistant Professor of Oncology
  • Assistant Professor of Pediatrics

Departments / Divisions

Education

Degrees

  • MD; Georgetown University School of Medicine (2009)

Residencies

  • Pediatrics; Johns Hopkins University School of Medicine (2012)

Fellowships

  • Pediatric Hematology-Oncology; Texas Children's Hospital (2015)

Board Certifications

  • American Board of Pediatrics (Hematology-Oncology) (2017)
  • American Board of Pediatrics (Pediatrics-General) (2014)

Research & Publications

Selected Publications

Bonifant CL, Szoor A, Torres D, Joseph N, Velasquez MP, Iwahori K, Gaikwad A, Nguyen P, Arber C, Song XT, Redell M, Gottschalk S. CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia. Molecular Therapy: The Journal of the American Society of Gene Therapy. 2016; 24(9):1615-26.

Bonifant CL, Jackson HJ, Brentjens RJ, Curran KJ. Toxicity and management in CAR T-cell therapy. Molecular Therapy Oncolytics. 2016; 3:16011.

Bonifant CL, Velasquez MP, Gottschalk S. Advances in immunotherapy for pediatric acute myeloid leukemia. Expert Opinion on Biological Therapy. 2018; 18(1):51-63.

Zolov SN, Rietberg SP, Bonifant CL. Programmed cell death protein 1 activation preferentially inhibits CD28.CAR-T cells. Cytotherapy. 2018; 20(10):1259-1266.

Krawczyk E, Zolov SN, Huang K, Bonifant CL. T-cell Activity against AML Improved by Dual-Targeted T Cells Stimulated through T-cell and IL7 Receptors. Cancer Immunology Research. 2019; 7(4):683-692.

Patents

Combination CD123 and C-type Lectin Molecule 1 Targeted T cells for Acute Myeloid Leukemia (Co-Inventor)
Patent # US Provisional Patent Application No. 62/398,859, PCT application US2017/052989 | 

Chimeric Antigen Receptor Comprised of CD123 Binding Domain and IL-7 Intracellular Signaling Domain
Patent # US Provisional Patent Application No. 16/644,900, PCT application No. 16/358,253 | 

Chimeric Antigen Receptors Targeting Abnormal Glycobiology (Co-inventor)
Patent # US Provisional Application No. 62/802,001 | 

Activities & Honors

Honors

  • 2018 Damon Runyon-Jake Wetchler Award for Pediatric Innovation, Damon Runyon Foundation-Jake Wetchler Foundation, 2018

Memberships

  • American Academy of Pediatrics, 2009
  • American Society of Hematology, 2012
  • American Society of Bone Marrow Transplantation, 2015
Is this you? Edit Profile
back to top button